The Link Between Rheumatoid Arthritis and Your Lungs
At a Glance
RA-ILD occurs when rheumatoid arthritis-related immune activity affects lung tissue and may lead to inflammation, abnormal repair, and scarring. Lung changes can appear on high-resolution CT before breathing symptoms or joint problems, and smoking may increase risk.
Discovering that rheumatoid arthritis (RA) can affect your lungs is often a confusing and overwhelming experience. It is natural to feel blindsided—you may have spent years focusing on your joints, only to find that your breathing has become part of the conversation [1].
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) is a condition where the immune system begins to attack the delicate tissues of the lungs [2]. While RA is widely known as a joint disease, it is a “systemic” condition, meaning it can affect various parts of the body beyond the hands and knees [3].
Understanding the Numbers
If you have seen a report mentioning “lung abnormalities,” it is important to know that imaging findings are more common than actual symptoms.
- Imaging vs. Symptoms: Research suggests that around 19% of people in some HRCT-screened RA cohorts have signs of interstitial lung disease (ILD) on a high-resolution CT (HRCT) scan, depending heavily on the population screened [4].
- Clinically Evident Disease: A smaller percentage of patients develop “clinically evident” disease—the kind that causes noticeable symptoms like shortness of breath or a persistent dry cough [1].
- Subclinical Findings: Many people have “subclinical” disease, meaning the scan shows very mild changes that do not yet affect their daily life or breathing [5]. In one early-RA study, over 60% of cases found on scans were subclinical [5].
When the Lungs Lead the Way
It may surprise you to learn that for some people, the lungs are actually the first part of the body to show signs of RA. This is known as a lung-first presentation [6].
- In a subset of cases, lung symptoms or imaging changes appear before any joint pain or swelling begins [6].
- In some instances, these lung changes can precede joint symptoms by months or even years [7].
- Often, patients are found to have the same “autoantibodies” (proteins like Rheumatoid Factor or ACPA) in their blood that are seen in joint-focused RA, even if their joints feel fine at the time [7].
The Biology: Why the Lungs?
Scientists are still piecing together exactly why this happens, but a leading hypothesis involves mucosal autoimmunity—the idea that the immune system’s confusion might actually start in the “mucosa” (the lining) of the lungs rather than the joints [3].
- The Trigger: Inhaled irritants, most notably cigarette smoke, can irritate the lung lining [8]. Other factors like air pollution or certain dusts may also play a role [9].
- Citrullination: This irritation can cause a process called citrullination, where normal proteins in the lung are changed into a shape the body no longer recognizes [10].
- The Immune Response: The immune system sees these “citrullinated” proteins as invaders and creates anti-citrullinated protein antibodies (ACPA) to attack them [11]. Once the immune system is “primed” in the lungs, it may eventually involve similar proteins in the joints [1].
- Abnormal Repair: Normally, when lung tissue is injured, the body repairs it. In RA-ILD, the repair process goes off track. Instead of healing, the body produces too much tough, fibrous tissue (collagen), leading to fibrosis (scarring) [2][3]. This scarring makes the lung tissue stiff, which makes it harder for the lungs to expand and take in oxygen [2].
Genetic and Environmental Links
Not everyone with RA will develop lung issues. It usually requires a combination of “nature and nurture.” You may have a genetic predisposition—certain gene variants (such as the MUC5B variant) can make the lungs more vulnerable, though genetic testing is not routine for most patients [12]. When these genetic associations meet an environmental trigger like smoking, the risk of the immune system attacking the lungs increases significantly [8][3]. Improving our understanding of these mechanisms is helping doctors move toward more personalized ways of monitoring and managing the disease [13].
Common questions in this guide
What is RA-ILD, and how can it affect the lungs?
Can RA-ILD show up on a scan before I notice symptoms?
Can lung problems happen before rheumatoid arthritis joint symptoms?
What increases the risk of rheumatoid arthritis-related lung disease?
What does subclinical interstitial lung disease mean?
Which RA-ILD symptoms should I discuss with my doctor?
Get notified when new evidence is published on rheumatoid arthritis-associated interstitial lung disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.
Paulin F, Doyle TJ, Fletcher EA, et al.
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2015; (67(5)):280-6.
PMID: 26696331 - 2
Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management.
Gao R, Liu S, Song L
Respiratory medicine 2026; (261()):109066 doi:10.1016/j.rmed.2026.109066.
PMID: 42521038 - 3
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.
McDermott GC, Hayashi K, Juge PA, et al.
Arthritis care & research 2025; (77(2)):185-194 doi:10.1002/acr.25432.
PMID: 39257341 - 4
Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening.
Ikdahl E, Mangseth H
Scandinavian journal of rheumatology 2026; (55(1)):59-67 doi:10.1080/03009742.2025.2538946.
PMID: 40923993 - 5
Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study.
Mena-Vázquez N, Domínguez-Álvaro M, Bonilla Hernán MG, et al.
RMD open 2026; (12(2)) doi:10.1136/rmdopen-2026-006934.
PMID: 42150840 - 6
A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis.
Khan T, Jose RJ, Renzoni EA, Mouyis M
Rheumatology and therapy 2021; (8(4)):1463-1475 doi:10.1007/s40744-021-00362-4.
PMID: 34449068 - 7
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
Cassone G, Sebastiani M, Vacchi C, et al.
Respiratory medicine case reports 2020; (30()):101051 doi:10.1016/j.rmcr.2020.101051.
PMID: 32292694 - 8
Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis.
Johnson C, Giles JT, Bathon J, et al.
PloS one 2016; (11(4)):e0153024 doi:10.1371/journal.pone.0153024.
PMID: 27050433 - 9
PM10 increases mortality risk in rheumatoid arthritis-associated interstitial lung disease.
Kim SH, Kim SY, Yoon HY, Song JW
RMD open 2024; (10(1)) doi:10.1136/rmdopen-2023-003680.
PMID: 38331470 - 10
Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.
Samara KD, Trachalaki A, Tsitoura E, et al.
Respiratory research 2017; (18(1)):218 doi:10.1186/s12931-017-0692-9.
PMID: 29287593 - 11
Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Zhang M, Yin J, Zhang X
PloS one 2023; (18(6)):e0286191 doi:10.1371/journal.pone.0286191.
PMID: 37352174 - 12
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.
Juge PA, Borie R, Kannengiesser C, et al.
The European respiratory journal 2017; (49(5)) doi:10.1183/13993003.02314-2016.
PMID: 28495692 - 13
Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
Wan J, Yu Z, Cao X, et al.
Clinical rheumatology 2024; (43(6)):1855-1863 doi:10.1007/s10067-024-06984-7.
PMID: 38704780
This page explains how rheumatoid arthritis can affect the lungs for educational purposes only and does not replace medical advice. Your doctor or lung specialist should interpret your symptoms and scans and advise you about monitoring and care.